<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 08:56PM UTC 2026-05-08--><xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2026" xmlns:currency="http://xbrl.sec.gov/currency/2026" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ecd="http://xbrl.sec.gov/ecd/2026" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:exch="http://xbrl.sec.gov/exch/2026" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2026" xmlns:sic="http://xbrl.sec.gov/sic/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:srt-types="http://fasb.org/srt-types/2026" xmlns:stpr="http://xbrl.sec.gov/stpr/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:us-types="http://fasb.org/us-types/2026" xmlns:vxrt="http://www.vaxart.com/20251231" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.vaxart.com/20251231">
  <xsd:import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/ecd/2026" schemaLocation="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/exch/2026" schemaLocation="https://xbrl.sec.gov/exch/2026/exch-2026.xsd"/>
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/currency/2026" schemaLocation="https://xbrl.sec.gov/currency/2026/currency-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/country/2026" schemaLocation="https://xbrl.sec.gov/country/2026/country-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/naics/2026" schemaLocation="https://xbrl.sec.gov/naics/2026/naics-2026.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xsd:import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2026" schemaLocation="https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/sic/2026" schemaLocation="https://xbrl.sec.gov/sic/2026/sic-2026.xsd"/>
  <xsd:import namespace="http://fasb.org/us-types/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xsd:import namespace="http://fasb.org/srt-types/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd"/>
  <xsd:import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vxrt-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vxrt-20251231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vxrt-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vxrt-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="statement-document-and-entity-information" roleURI="http://www.vaxart.com/20251231/role/statement-document-and-entity-information">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-condensed-consolidated-balance-sheets-current-period-unaudited" roleURI="http://www.vaxart.com/20251231/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" roleURI="http://www.vaxart.com/20251231/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-condensed-consolidated-statements-of-operations-and-comprehensive-income-loss-unaudited" roleURI="http://www.vaxart.com/20251231/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-income-loss-unaudited">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" roleURI="http://www.vaxart.com/20251231/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-condensed-consolidated-statements-of-cash-flows-unaudited" roleURI="http://www.vaxart.com/20251231/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-balance-sheets" roleURI="http://www.vaxart.com/20251231/role/statement-consolidated-balance-sheets">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">006 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-balance-sheets-parentheticals" roleURI="http://www.vaxart.com/20251231/role/statement-consolidated-balance-sheets-parentheticals">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">007 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statements-of-operations-and-comprehensive-income-loss-" roleURI="http://www.vaxart.com/20251231/role/statement-consolidated-statements-of-operations-and-comprehensive-income-loss-">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">008 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statements-of-stockholders-equity" roleURI="http://www.vaxart.com/20251231/role/statement-consolidated-statements-of-stockholders-equity">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">009 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statements-of-stockholders-equity-parentheticals" roleURI="http://www.vaxart.com/20251231/role/statement-consolidated-statements-of-stockholders-equity-parentheticals">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">010 - Statement - Consolidated Statements of Stockholders' Equity (Parentheticals)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statements-of-cash-flows" roleURI="http://www.vaxart.com/20251231/role/statement-consolidated-statements-of-cash-flows">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">011 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-organization-and-nature-of-business-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-1-organization-and-nature-of-business-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">012 - Disclosure - Note 1 - Organization and Nature of Business 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-summary-of-significant-accounting-policies-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">013 - Disclosure - Note 2 - Summary of Significant Accounting Policies 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-fair-value-of-financial-instruments-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-3-fair-value-of-financial-instruments-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">014 - Disclosure - Note 3 - Fair Value of Financial Instruments 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">015 - Disclosure - Note 4 - Balance Sheet Components 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-revenue-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-5-revenue-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">016 - Disclosure - Note 5 - Revenue 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-liabilities-related-to-sale-of-future-royalties-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-6-liabilities-related-to-sale-of-future-royalties-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">017 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-leases-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-7-leases-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">018 - Disclosure - Note 7 - Leases 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-commitments-and-contingencies-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-8-commitments-and-contingencies-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">019 - Disclosure - Note 8 - Commitments and Contingencies 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stockholders-equity-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-9-stockholders-equity-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">020 - Disclosure - Note 9 - Stockholders' Equity 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">021 - Disclosure - Note 10 - Equity Incentive Plans 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">022 - Disclosure - Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-segment-reporting-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">023 - Disclosure - Note 12 - Segment Reporting 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-subsequent-events-1" roleURI="http://www.vaxart.com/20251231/role/statement-note-13-subsequent-events-1">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">024 - Disclosure - Note 13 - Subsequent Events 1</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-organization-and-nature-of-business" roleURI="http://www.vaxart.com/20251231/role/statement-note-1-organization-and-nature-of-business">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">025 - Disclosure - Note 1 - Organization and Nature of Business</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-summary-of-significant-accounting-policies" roleURI="http://www.vaxart.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">026 - Disclosure - Note 2 - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-fair-value-of-financial-instruments" roleURI="http://www.vaxart.com/20251231/role/statement-note-3-fair-value-of-financial-instruments">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">027 - Disclosure - Note 3 - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">028 - Disclosure - Note 4 - Balance Sheet Components</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-revenue" roleURI="http://www.vaxart.com/20251231/role/statement-note-5-revenue">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">029 - Disclosure - Note 5 - Revenue</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-liabilities-related-to-sale-of-future-royalties" roleURI="http://www.vaxart.com/20251231/role/statement-note-6-liabilities-related-to-sale-of-future-royalties">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">030 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-leases" roleURI="http://www.vaxart.com/20251231/role/statement-note-7-leases">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">031 - Disclosure - Note 7 - Leases</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-commitments-and-contingencies" roleURI="http://www.vaxart.com/20251231/role/statement-note-8-commitments-and-contingencies">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">032 - Disclosure - Note 8 - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stockholders-equity" roleURI="http://www.vaxart.com/20251231/role/statement-note-9-stockholders-equity">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">033 - Disclosure - Note 9 - Stockholders' Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">034 - Disclosure - Note 10 - Equity Incentive Plans</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-benefit-plan" roleURI="http://www.vaxart.com/20251231/role/statement-note-11-benefit-plan">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">035 - Disclosure - Note 11 - Benefit Plan</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-income-taxes" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-income-taxes">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">036 - Disclosure - Note 12 - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-net-income-loss-per-share-attributable-to-common-stockholders" roleURI="http://www.vaxart.com/20251231/role/statement-note-13-net-income-loss-per-share-attributable-to-common-stockholders">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">037 - Disclosure - Note 13 - Net Income (Loss) Per Share Attributable to Common Stockholders</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-14-segment-reporting" roleURI="http://www.vaxart.com/20251231/role/statement-note-14-segment-reporting">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">038 - Disclosure - Note 14 - Segment Reporting</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-15-subsequent-events-" roleURI="http://www.vaxart.com/20251231/role/statement-note-15-subsequent-events-">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">039 - Disclosure - Note 15 - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-significant-accounting-policies-policies" roleURI="http://www.vaxart.com/20251231/role/statement-significant-accounting-policies-policies">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">040 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-fair-value-of-financial-instruments-1-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-3-fair-value-of-financial-instruments-1-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">041 - Disclosure - Note 3 - Fair Value of Financial Instruments 1 (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-1-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-1-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">042 - Disclosure - Note 4 - Balance Sheet Components 1 (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-liabilities-related-to-sale-of-future-royalties-1-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-6-liabilities-related-to-sale-of-future-royalties-1-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">043 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties 1 (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-leases-1-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-7-leases-1-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">044 - Disclosure - Note 7 - Leases 1 (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stockholders-equity-1-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-9-stockholders-equity-1-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">045 - Disclosure - Note 9 - Stockholders' Equity 1 (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans-1-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans-1-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">046 - Disclosure - Note 10 - Equity Incentive Plans 1 (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-1-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-1-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">047 - Disclosure - Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders 1 (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-1-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-segment-reporting-1-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">048 - Disclosure - Note 12 - Segment Reporting 1 (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-summary-of-significant-accounting-policies-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">049 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-fair-value-of-financial-instruments-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-3-fair-value-of-financial-instruments-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">050 - Disclosure - Note 3 - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">051 - Disclosure - Note 4 - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-liabilities-related-to-sale-of-future-royalties-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-6-liabilities-related-to-sale-of-future-royalties-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">052 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-leases-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-7-leases-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">053 - Disclosure - Note 7 - Leases (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stockholders-equity-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-9-stockholders-equity-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">054 - Disclosure - Note 9 - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">055 - Disclosure - Note 10 - Equity Incentive Plans (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-income-taxes-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-income-taxes-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">056 - Disclosure - Note 12 - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-net-income-loss-per-share-attributable-to-common-stockholders-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-13-net-income-loss-per-share-attributable-to-common-stockholders-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">057 - Disclosure - Note 13 - Net Income (Loss) Per Share Attributable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-14-segment-reporting-tables" roleURI="http://www.vaxart.com/20251231/role/statement-note-14-segment-reporting-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">058 - Disclosure - Note 14 - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-organization-and-nature-of-business-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-1-organization-and-nature-of-business-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">059 - Disclosure - Note 1 - Organization and Nature of Business 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-summary-of-significant-accounting-policies-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">060 - Disclosure - Note 2 - Summary of Significant Accounting Policies 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-fair-value-of-financial-instruments-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-3-fair-value-of-financial-instruments-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">061 - Disclosure - Note 3 - Fair Value of Financial Instruments 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-fair-value-of-financial-instruments-financial-assets-measured-on-a-recurring-basis-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-3-fair-value-of-financial-instruments-financial-assets-measured-on-a-recurring-basis-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">062 - Disclosure - Note 3 - Fair Value of Financial Instruments - Financial Assets Measured on a Recurring Basis 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">063 - Disclosure - Note 4 - Balance Sheet Components 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-cash-and-cash-equivalents-and-investments-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-cash-and-cash-equivalents-and-investments-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">064 - Disclosure - Note 4 - Balance Sheet Components - Cash and Cash Equivalents and Investments 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-prepaid-expenses-and-other-current-assets-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-prepaid-expenses-and-other-current-assets-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">065 - Disclosure - Note 4 - Balance Sheet Components - Prepaid Expenses and Other Current Assets 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-property-and-equipment-net-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-property-and-equipment-net-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">066 - Disclosure - Note 4 - Balance Sheet Components - Property and Equipment, Net 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-intangible-assets-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-intangible-assets-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">067 - Disclosure - Note 4 - Balance Sheet Components - Intangible Assets 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-estimated-future-amortization-expense-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-estimated-future-amortization-expense-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">068 - Disclosure - Note 4 - Balance Sheet Components - Estimated Future Amortization Expense 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-deferred-revenue-by-arrangement-disclosure-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-deferred-revenue-by-arrangement-disclosure-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">069 - Disclosure - Note 4 - Balance Sheet Components - Deferred Revenue, by Arrangement, Disclosure 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-accrued-liabilities-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-accrued-liabilities-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">070 - Disclosure - Note 4 - Balance Sheet Components - Accrued Liabilities 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-revenue-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-5-revenue-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">071 - Disclosure - Note 5 - Revenue 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-liabilities-related-to-sale-of-future-royalties-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-6-liabilities-related-to-sale-of-future-royalties-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">072 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-liabilities-related-to-sale-of-future-royalties-deferred-revenue-activity-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-6-liabilities-related-to-sale-of-future-royalties-deferred-revenue-activity-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">073 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties - Deferred Revenue Activity 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-leases-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-7-leases-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">074 - Disclosure - Note 7 - Leases 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-leases-lease-liabilities-payment-obligations-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-7-leases-lease-liabilities-payment-obligations-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">075 - Disclosure - Note 7 - Leases - Lease Liabilities Payment Obligations 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-leases-operating-lease-expenses-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-7-leases-operating-lease-expenses-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">076 - Disclosure - Note 7 - Leases - Operating Lease Expenses 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-commitments-and-contingencies-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-8-commitments-and-contingencies-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">077 - Disclosure - Note 8 - Commitments and Contingencies 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stockholders-equity-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-9-stockholders-equity-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">078 - Disclosure - Note 9 - Stockholders' Equity 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stockholders-equity-shares-of-common-stock-reserved-for-issuance-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-9-stockholders-equity-shares-of-common-stock-reserved-for-issuance-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">079 - Disclosure - Note 9 - Stockholders' Equity - Shares of Common Stock Reserved for Issuance 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stockholders-equity-summary-of-warrants-outstanding-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-9-stockholders-equity-summary-of-warrants-outstanding-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">080 - Disclosure - Note 9 - Stockholders' Equity - Summary of Warrants Outstanding 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">081 - Disclosure - Note 10 - Equity Incentive Plans 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans-summary-of-stock-option-transactions-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans-summary-of-stock-option-transactions-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">082 - Disclosure - Note 10 - Equity Incentive Plans - Summary of Stock Option Transactions 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans-assumptions-of-options-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans-assumptions-of-options-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">083 - Disclosure - Note 10 - Equity Incentive Plans - Assumptions of Options 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans-total-stockbased-compensation-recognized-for-options-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans-total-stockbased-compensation-recognized-for-options-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">084 - Disclosure - Note 10 - Equity Incentive Plans - Total Stock-based Compensation Recognized for Options 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">085 - Disclosure - Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-calculation-of-basic-and-diluted-net-loss-income-per-share-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-calculation-of-basic-and-diluted-net-loss-income-per-share-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">086 - Disclosure - Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders - Calculation of Basic and Diluted Net (Loss) Income Per Share 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-summary-of-antidilutive-securities-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-summary-of-antidilutive-securities-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">087 - Disclosure - Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-segment-reporting-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">088 - Disclosure - Note 12 - Segment Reporting 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-schedule-of-segment-reporting-information-by-segment-1-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-segment-reporting-schedule-of-segment-reporting-information-by-segment-1-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">089 - Disclosure - Note 12 - Segment Reporting - Schedule of Segment Reporting Information, by Segment 1 (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-subsequent-events-1-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-13-subsequent-events-1-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">090 - Disclosure - Note 13 - Subsequent Events 1 (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-organization-and-nature-of-business-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-1-organization-and-nature-of-business-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">091 - Disclosure - Note 1 - Organization and Nature of Business (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-summary-of-significant-accounting-policies-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">092 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-summary-of-significant-accounting-policies-estimated-useful-lives-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-estimated-useful-lives-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">093 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Estimated Useful Lives (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-fair-value-of-financial-instruments-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-3-fair-value-of-financial-instruments-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">094 - Disclosure - Note 3 - Fair Value of Financial Instruments (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-fair-value-of-financial-instruments-financial-assets-measured-on-a-recurring-basis-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-3-fair-value-of-financial-instruments-financial-assets-measured-on-a-recurring-basis-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">095 - Disclosure - Note 3 - Fair Value of Financial Instruments - Financial Assets Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">096 - Disclosure - Note 4 - Balance Sheet Components (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-cash-and-cash-equivalents-and-investments-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-cash-and-cash-equivalents-and-investments-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">097 - Disclosure - Note 4 - Balance Sheet Components - Cash and Cash Equivalents and Investments (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-prepaid-expenses-and-other-current-assets-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-prepaid-expenses-and-other-current-assets-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">098 - Disclosure - Note 4 - Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-property-and-equipment-net-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-property-and-equipment-net-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">099 - Disclosure - Note 4 - Balance Sheet Components - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-intangible-assets-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-intangible-assets-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">100 - Disclosure - Note 4 - Balance Sheet Components - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-estimated-future-amortization-expense-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-estimated-future-amortization-expense-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">101 - Disclosure - Note 4 - Balance Sheet Components - Estimated Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-deferred-revenue-by-arrangement-disclosure-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-deferred-revenue-by-arrangement-disclosure-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">102 - Disclosure - Note 4 - Balance Sheet Components - Deferred Revenue, by Arrangement, Disclosure (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-balance-sheet-components-accrued-liabilities-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-4-balance-sheet-components-accrued-liabilities-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">103 - Disclosure - Note 4 - Balance Sheet Components - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-revenue-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-5-revenue-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">104 - Disclosure - Note 5 - Revenue (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-liabilities-related-to-sale-of-future-royalties-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-6-liabilities-related-to-sale-of-future-royalties-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">105 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-liabilities-related-to-sale-of-future-royalties-deferred-revenue-activity-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-6-liabilities-related-to-sale-of-future-royalties-deferred-revenue-activity-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">106 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties - Deferred Revenue Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-leases-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-7-leases-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">107 - Disclosure - Note 7 - Leases (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-leases-lease-liabilities-payment-obligations-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-7-leases-lease-liabilities-payment-obligations-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">108 - Disclosure - Note 7 - Leases - Lease Liabilities Payment Obligations (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-leases-operating-lease-expenses-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-7-leases-operating-lease-expenses-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">109 - Disclosure - Note 7 - Leases - Operating Lease Expenses (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-commitments-and-contingencies-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-8-commitments-and-contingencies-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">110 - Disclosure - Note 8 - Commitments and Contingencies (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stockholders-equity-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-9-stockholders-equity-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">111 - Disclosure - Note 9 - Stockholders' Equity (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stockholders-equity-shares-of-common-stock-reserved-for-issuance-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-9-stockholders-equity-shares-of-common-stock-reserved-for-issuance-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">112 - Disclosure - Note 9 - Stockholders' Equity - Shares of Common Stock Reserved for Issuance (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stockholders-equity-summary-of-warrants-outstanding-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-9-stockholders-equity-summary-of-warrants-outstanding-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">113 - Disclosure - Note 9 - Stockholders' Equity - Summary of Warrants Outstanding (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">114 - Disclosure - Note 10 - Equity Incentive Plans (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans-summary-of-stock-option-transactions-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans-summary-of-stock-option-transactions-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">115 - Disclosure - Note 10 - Equity Incentive Plans - Summary of Stock Option Transactions (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans-assumptions-of-options-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans-assumptions-of-options-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">116 - Disclosure - Note 10 - Equity Incentive Plans - Assumptions of Options (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-equity-incentive-plans-total-stockbased-compensation-recognized-for-options-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-10-equity-incentive-plans-total-stockbased-compensation-recognized-for-options-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">117 - Disclosure - Note 10 - Equity Incentive Plans - Total Stock-based Compensation Recognized for Options (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-benefit-plan-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-11-benefit-plan-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">118 - Disclosure - Note 11 - Benefit Plan (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-income-taxes-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-income-taxes-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">119 - Disclosure - Note 12 - Income Taxes (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-income-taxes-schedule-of-income-before-income-tax-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-income-taxes-schedule-of-income-before-income-tax-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">120 - Disclosure - Note 12 - Income Taxes - Schedule of Income Before Income Tax (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-income-taxes-components-of-income-tax-expense-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-income-taxes-components-of-income-tax-expense-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">121 - Disclosure - Note 12 - Income Taxes - Components of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-income-taxes-components-of-deferred-tax-assets-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-income-taxes-components-of-deferred-tax-assets-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">122 - Disclosure - Note 12 - Income Taxes - Components of Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-income-taxes-reconciliation-of-effective-tax-rate-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-income-taxes-reconciliation-of-effective-tax-rate-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">123 - Disclosure - Note 12 - Income Taxes - Reconciliation of Effective Tax Rate (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-income-taxes-income-taxes-paid-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-income-taxes-income-taxes-paid-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">124 - Disclosure - Note 12 - Income Taxes - Income Taxes Paid (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-income-taxes-schedule-of-state-and-local-income-tax-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-income-taxes-schedule-of-state-and-local-income-tax-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">125 - Disclosure - Note 12 - Income Taxes - Schedule of State and Local Income Tax (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-income-taxes-unrecognized-tax-benefits-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-12-income-taxes-unrecognized-tax-benefits-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">126 - Disclosure - Note 12 - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-net-loss-per-share-attributable-to-common-stockholders-calculation-of-basic-and-diluted-net-loss-income-per-share-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-13-net-loss-per-share-attributable-to-common-stockholders-calculation-of-basic-and-diluted-net-loss-income-per-share-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">127 - Disclosure - Note 13 - Net Loss Per Share Attributable to Common Stockholders - Calculation of Basic and Diluted Net (Loss) Income Per Share (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-net-loss-per-share-attributable-to-common-stockholders-summary-of-antidilutive-securities-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-13-net-loss-per-share-attributable-to-common-stockholders-summary-of-antidilutive-securities-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">128 - Disclosure - Note 13 - Net Loss Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-14-segment-reporting-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-14-segment-reporting-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">129 - Disclosure - Note 14 - Segment Reporting (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-14-segment-reporting-schedule-of-segment-reporting-information-by-segment-details" roleURI="http://www.vaxart.com/20251231/role/statement-note-14-segment-reporting-schedule-of-segment-reporting-information-by-segment-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">130 - Disclosure - Note 14 - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-15-subsequent-events-details-textual" roleURI="http://www.vaxart.com/20251231/role/statement-note-15-subsequent-events-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">131 - Disclosure - Note 15 - Subsequent Events (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="vxrt_AccruedClinicalAndManufacturingExpensesCurrent" name="AccruedClinicalAndManufacturingExpensesCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock" name="AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_AdjustmentsToRightofuseAssetFromLeaseModification" name="AdjustmentsToRightofuseAssetFromLeaseModification" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_AtthemarketFacilityMember" name="AtthemarketFacilityMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_BARDAMember" name="BARDAMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ClassOfWarrantOrRightExpirationsInPeriod" name="ClassOfWarrantOrRightExpirationsInPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_ClinicalResearchOrganizationAndAnalyticalTestingVendorMember" name="ClinicalResearchOrganizationAndAnalyticalTestingVendorMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_ClinicalResearchOrganizationMember" name="ClinicalResearchOrganizationMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_ClinicalResearchOrganizerAndAnalyticTestingVendorMember" name="ClinicalResearchOrganizerAndAnalyticTestingVendorMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_CollaborationRevenueMember" name="CollaborationRevenueMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_CommonStockCapitalSharesReservedForFutureIssuanceIncrease" name="CommonStockCapitalSharesReservedForFutureIssuanceIncrease" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_CommonStockIncreaseInSharesAuthorized" name="CommonStockIncreaseInSharesAuthorized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_CommonStockOutstandingMember" name="CommonStockOutstandingMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_CommonWarrantsMember" name="CommonWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ContractWithCustomerLiabilityAmountCollectedOrInvoiced" name="ContractWithCustomerLiabilityAmountCollectedOrInvoiced" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance" name="ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_CostplufixedfeesArrangementUnderATIRRPVContractMember" name="CostplufixedfeesArrangementUnderATIRRPVContractMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_CostplusfixedfeeMember" name="CostplusfixedfeeMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_Covid19ProgramMember" name="Covid19ProgramMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_DaiichiSankyoCollaberationAndLicenseAgreementMember" name="DaiichiSankyoCollaberationAndLicenseAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_DaiichiSankyoMember" name="DaiichiSankyoMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_DebtNoncashInterestExpenseRecognized" name="DebtNoncashInterestExpenseRecognized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_DebtNoncashRoyaltyRevenuePaid" name="DebtNoncashRoyaltyRevenuePaid" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_DeferredTaxAssetsCapitalizedResearchAndDevelopment" name="DeferredTaxAssetsCapitalizedResearchAndDevelopment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_DeferredTaxAssetsLeaseLiabilities" name="DeferredTaxAssetsLeaseLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_DeferredTaxAssetsSaleOfFutureRoyaltyRights" name="DeferredTaxAssetsSaleOfFutureRoyaltyRights" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="vxrt_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_ESPPMember" name="ESPPMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_EffectiveIncomeTaxRateReconciliationChangesInUnrecognizedTaxBenefitsAmount" name="EffectiveIncomeTaxRateReconciliationChangesInUnrecognizedTaxBenefitsAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_EffectiveIncomeTaxRateReconciliationChangesInUnrecognizedTaxBenefitsPercent" name="EffectiveIncomeTaxRateReconciliationChangesInUnrecognizedTaxBenefitsPercent" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_EffectiveIncomeTaxRateReconciliationForeignAmount" name="EffectiveIncomeTaxRateReconciliationForeignAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_EffectiveIncomeTaxRateReconciliationForeignPercent" name="EffectiveIncomeTaxRateReconciliationForeignPercent" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_EffectiveIncomeTaxRateReconciliationTaxCreditsAmount" name="EffectiveIncomeTaxRateReconciliationTaxCreditsAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_EffectiveIncomeTaxRateReconciliationTaxCreditsPercent" name="EffectiveIncomeTaxRateReconciliationTaxCreditsPercent" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_ElectionPaymentMember" name="ElectionPaymentMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_EquityOfferingMaximumAmount" name="EquityOfferingMaximumAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_EqupercentOfShareOwnership" name="EqupercentOfShareOwnership" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="vxrt_FacilityInBurlingameCaliforniaMember" name="FacilityInBurlingameCaliforniaMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_FacilityInSouthSanFranciscoMember" name="FacilityInSouthSanFranciscoMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_FinitelivedIntangibleAssetRemainingLife" name="FinitelivedIntangibleAssetRemainingLife" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_FirmFixedpriceMilestoneMember" name="FirmFixedpriceMilestoneMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_GainLossOnModificationOfLeaseLiability" name="GainLossOnModificationOfLeaseLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_GeneralAndAdministrativeMember" name="GeneralAndAdministrativeMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_GovernmentAssistanceAwardAmountInitialAward" name="GovernmentAssistanceAwardAmountInitialAward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_GovernmentContractAdditionalFundingPossible" name="GovernmentContractAdditionalFundingPossible" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_GovernmentContractAmountAuthorizedMilestones" name="GovernmentContractAmountAuthorizedMilestones" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_GovernmentContractAwardAmountAllottedAndAvailable" name="GovernmentContractAwardAmountAllottedAndAvailable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_GovernmentContractAwardAmountInitialAwardFixedFee" name="GovernmentContractAwardAmountInitialAwardFixedFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_GrossProceedsFromIssuanceOfCommonStock" name="GrossProceedsFromIssuanceOfCommonStock" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_HCRPMember" name="HCRPMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_HealthcareRoyaltyIIILPMember" name="HealthcareRoyaltyIIILPMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_HhsBardaMember" name="HhsBardaMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_HimmelbergVVaxartIncEtAlMember" name="HimmelbergVVaxartIncEtAlMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_IncomeTaxStateIncomeTaxesPaidPercentageOfAllStates" name="IncomeTaxStateIncomeTaxesPaidPercentageOfAllStates" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_IncreaseDecreaseInUnbilledReceivable" name="IncreaseDecreaseInUnbilledReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_InternalResearchAndDevelopmentCostsMember" name="InternalResearchAndDevelopmentCostsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_InvestmentsAndCashFairValueDisclosure" name="InvestmentsAndCashFairValueDisclosure" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="vxrt_June2024OfferingMember" name="June2024OfferingMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_LeaseForFacilityInSouthSanFranciscoCommencedInFirstQuarterOf2023Member" name="LeaseForFacilityInSouthSanFranciscoCommencedInFirstQuarterOf2023Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_LesseeOperatingLeaseNumberOfLeases" name="LesseeOperatingLeaseNumberOfLeases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_LesseeShortTermLeaseNumberOfLeases" name="LesseeShortTermLeaseNumberOfLeases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_LiabilitiesRelatedToSaleOfFutureRoyaltiesTextBlock" name="LiabilitiesRelatedToSaleOfFutureRoyaltiesTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_LiabilityRelatedToSaleOfFutureRoyalties" name="LiabilityRelatedToSaleOfFutureRoyalties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesCurrent" name="LiabilityRelatedToSaleOfFutureRoyaltiesCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent" name="LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="vxrt_LicenseAgreementAndPurchaseAgreementMember" name="LicenseAgreementAndPurchaseAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_LicenseAgreementConsideration" name="LicenseAgreementConsideration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_LicenseAgreementFeeToBeReceived" name="LicenseAgreementFeeToBeReceived" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_LicenseAgreementPremium" name="LicenseAgreementPremium" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_LicenseAgreementProceedsToBeReceived" name="LicenseAgreementProceedsToBeReceived" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_LicenseAgreementStockToBePurchasedAmount" name="LicenseAgreementStockToBePurchasedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_LicenseAgreementStockToBePurchasedPerShare" name="LicenseAgreementStockToBePurchasedPerShare" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_LicenseAgreementTotalTransactionCosts" name="LicenseAgreementTotalTransactionCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_LicenseAgreementTotalTransactionPrice" name="LicenseAgreementTotalTransactionPrice" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="vxrt_LpcElocPurchaseAgreementMember" name="LpcElocPurchaseAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_LpcMember" name="LpcMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_March2025AtmWithCitizensAndBRileyMember" name="March2025AtmWithCitizensAndBRileyMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_MassachusettsTaxAuthorityMember" name="MassachusettsTaxAuthorityMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_NonCashRoyaltyRevenueMember" name="NonCashRoyaltyRevenueMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_NoncashInterestExpenseOnLiability" name="NoncashInterestExpenseOnLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties" name="NoncashRevenueRelatedToSaleOfFutureRoyalties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_NorovirusProgramMember" name="NorovirusProgramMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_NoteToFinancialStatementDetailsTextual" name="NoteToFinancialStatementDetailsTextual" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_NotesToFinancialStatements" name="NotesToFinancialStatements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_OpenMarketSaleAgreementMaximumAggregateOfferingPrice" name="OpenMarketSaleAgreementMaximumAggregateOfferingPrice" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_OpenMarketSaleAgreementSalesCommissionPercentage" name="OpenMarketSaleAgreementSalesCommissionPercentage" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_OperatingLossCarryforwardCarriedForwardIndefinitely" name="OperatingLossCarryforwardCarriedForwardIndefinitely" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_OperatingLossCarryforwardsSubjectToExpiration" name="OperatingLossCarryforwardsSubjectToExpiration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="vxrt_OtherAccruedLiabilitiesMember" name="OtherAccruedLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_OtherProgramsMember" name="OtherProgramsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_PercentOfSharePriceForEquityOffering" name="PercentOfSharePriceForEquityOffering" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="vxrt_PolicyTable" name="PolicyTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_PreclinicalResearchMember" name="PreclinicalResearchMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_PremiumPaidForIssuanceOfEquity" name="PremiumPaidForIssuanceOfEquity" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_PrepaidClinicalAndManufacturingExpenses" name="PrepaidClinicalAndManufacturingExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_PrepaidExpensesAndPrepaidClinicalServicesPolicyTextBlock" name="PrepaidExpensesAndPrepaidClinicalServicesPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_PrepaidExpensesMember" name="PrepaidExpensesMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ProceedsFromIssuanceOrSaleOfEquityNet" name="ProceedsFromIssuanceOrSaleOfEquityNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ProceedsFromSaleOfFutureRoyaltiesNet" name="ProceedsFromSaleOfFutureRoyaltiesNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ProceedsFromStockPlansTreasuryStock" name="ProceedsFromStockPlansTreasuryStock" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_ProcessDevelopmentProgramMember" name="ProcessDevelopmentProgramMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_RACapitalHealthcareFund2024Member" name="RACapitalHealthcareFund2024Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_RaCapitalHealthcareFund2025Member" name="RaCapitalHealthcareFund2025Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_ReimbursablePurchaseAgreementCommitmentToVendorMember" name="ReimbursablePurchaseAgreementCommitmentToVendorMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_ResearchAndDevelopmentMember" name="ResearchAndDevelopmentMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_RevenueTextBlock" name="RevenueTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_RightOfUseForOfficeAndManufacturingFacilitiesWithInitialTermsExceedingOneYearMember" name="RightOfUseForOfficeAndManufacturingFacilitiesWithInitialTermsExceedingOneYearMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_RoyaltyInterestAdditionalRoyaltiesDueEachYear" name="RoyaltyInterestAdditionalRoyaltiesDueEachYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_RoyaltyInterestCovenantCumulativeRemainingShortfallAmount" name="RoyaltyInterestCovenantCumulativeRemainingShortfallAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_RoyaltyInterestCovenantShortfallInRoyaltyPayments" name="RoyaltyInterestCovenantShortfallInRoyaltyPayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="vxrt_RoyaltyInterestPercentageOfAdditionalRoyaltiesDueEachYear" name="RoyaltyInterestPercentageOfAdditionalRoyaltiesDueEachYear" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="vxrt_RoyaltyPaymentInterestFirstPeriodMember" name="RoyaltyPaymentInterestFirstPeriodMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_RoyaltyPaymentInterestSecondPeriodMember" name="RoyaltyPaymentInterestSecondPeriodMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_RoyaltyPercentage" name="RoyaltyPercentage" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_RoyaltyWithholdingTax" name="RoyaltyWithholdingTax" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_SanofiMember" name="SanofiMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_SanofiMergerWithDynavaxMember" name="SanofiMergerWithDynavaxMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" name="ScheduleOfCommonStockReservedForIssuanceTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ScheduleOfIncomeTaxByStateTableTextBlock" name="ScheduleOfIncomeTaxByStateTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ScheduleOfIncomeTaxesPaidTableTextBlock" name="ScheduleOfIncomeTaxesPaidTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" name="ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_September2021AtmMember" name="September2021AtmMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_September2021LeaseForFacilityInSouthSanFranciscoMember" name="September2021LeaseForFacilityInSouthSanFranciscoMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardCanceled" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardCanceled" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeited" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeited" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantDecreaseFromGrants" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantDecreaseFromGrants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_SharebasedCompensationArrangementBySharebasedPaymentAwardNonoptionEquityInstrumentsReleased" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonoptionEquityInstrumentsReleased" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_SouthSanFranciscoRealEstateMember" name="SouthSanFranciscoRealEstateMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlanTreasuryStock" name="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlanTreasuryStock" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="vxrt_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanTreasuryStock" name="StockIssuedDuringPeriodValueEmployeeStockPurchasePlanTreasuryStock" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_The2019PlanMember" name="The2019PlanMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_The2022EsppMember" name="The2022EsppMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_The2024AsprbardaContractMember" name="The2024AsprbardaContractMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_The2024AtirrpvContractMember" name="The2024AtirrpvContractMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_The2024InducementAwardPlanMember" name="The2024InducementAwardPlanMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_TheApril2026ATMMember" name="TheApril2026ATMMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_TheMarch2025AtmMember" name="TheMarch2025AtmMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_TheSeptember2021AtmMember" name="TheSeptember2021AtmMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_UnbilledReceivablesMember" name="UnbilledReceivablesMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_UtahAvenueLeaseMember" name="UtahAvenueLeaseMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_WarrantsExpiringDecember2026Member" name="WarrantsExpiringDecember2026Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_WarrantsExpiringMarch2025Member" name="WarrantsExpiringMarch2025Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-10-equity-incentive-plans-1-tables" name="statement-statement-note-10-equity-incentive-plans-1-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-10-equity-incentive-plans-assumptions-of-options-1-details" name="statement-statement-note-10-equity-incentive-plans-assumptions-of-options-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-10-equity-incentive-plans-assumptions-of-options-details" name="statement-statement-note-10-equity-incentive-plans-assumptions-of-options-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-10-equity-incentive-plans-summary-of-stock-option-transactions-1-details" name="statement-statement-note-10-equity-incentive-plans-summary-of-stock-option-transactions-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-10-equity-incentive-plans-summary-of-stock-option-transactions-details" name="statement-statement-note-10-equity-incentive-plans-summary-of-stock-option-transactions-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-10-equity-incentive-plans-tables" name="statement-statement-note-10-equity-incentive-plans-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-10-equity-incentive-plans-total-stockbased-compensation-recognized-for-options-1-details" name="statement-statement-note-10-equity-incentive-plans-total-stockbased-compensation-recognized-for-options-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-10-equity-incentive-plans-total-stockbased-compensation-recognized-for-options-details" name="statement-statement-note-10-equity-incentive-plans-total-stockbased-compensation-recognized-for-options-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-1-tables" name="statement-statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-1-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-calculation-of-basic-and-diluted-net-loss-income-per-share-1-details" name="statement-statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-calculation-of-basic-and-diluted-net-loss-income-per-share-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-summary-of-antidilutive-securities-1-details" name="statement-statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-summary-of-antidilutive-securities-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-12-income-taxes-components-of-deferred-tax-assets-details" name="statement-statement-note-12-income-taxes-components-of-deferred-tax-assets-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-12-income-taxes-components-of-income-tax-expense-details" name="statement-statement-note-12-income-taxes-components-of-income-tax-expense-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-12-income-taxes-income-taxes-paid-details" name="statement-statement-note-12-income-taxes-income-taxes-paid-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-12-income-taxes-reconciliation-of-effective-tax-rate-details" name="statement-statement-note-12-income-taxes-reconciliation-of-effective-tax-rate-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-12-income-taxes-schedule-of-income-before-income-tax-details" name="statement-statement-note-12-income-taxes-schedule-of-income-before-income-tax-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-12-income-taxes-schedule-of-state-and-local-income-tax-details" name="statement-statement-note-12-income-taxes-schedule-of-state-and-local-income-tax-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-12-income-taxes-tables" name="statement-statement-note-12-income-taxes-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-12-income-taxes-unrecognized-tax-benefits-details" name="statement-statement-note-12-income-taxes-unrecognized-tax-benefits-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-12-segment-reporting-1-tables" name="statement-statement-note-12-segment-reporting-1-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-12-segment-reporting-schedule-of-segment-reporting-information-by-segment-1-details" name="statement-statement-note-12-segment-reporting-schedule-of-segment-reporting-information-by-segment-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-13-net-income-loss-per-share-attributable-to-common-stockholders-tables" name="statement-statement-note-13-net-income-loss-per-share-attributable-to-common-stockholders-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-13-net-loss-per-share-attributable-to-common-stockholders-calculation-of-basic-and-diluted-net-loss-income-per-share-details" name="statement-statement-note-13-net-loss-per-share-attributable-to-common-stockholders-calculation-of-basic-and-diluted-net-loss-income-per-share-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-13-net-loss-per-share-attributable-to-common-stockholders-summary-of-antidilutive-securities-details" name="statement-statement-note-13-net-loss-per-share-attributable-to-common-stockholders-summary-of-antidilutive-securities-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-14-segment-reporting-schedule-of-segment-reporting-information-by-segment-details" name="statement-statement-note-14-segment-reporting-schedule-of-segment-reporting-information-by-segment-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-14-segment-reporting-tables" name="statement-statement-note-14-segment-reporting-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-2-summary-of-significant-accounting-policies-estimated-useful-lives-details" name="statement-statement-note-2-summary-of-significant-accounting-policies-estimated-useful-lives-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-2-summary-of-significant-accounting-policies-tables" name="statement-statement-note-2-summary-of-significant-accounting-policies-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-3-fair-value-of-financial-instruments-1-tables" name="statement-statement-note-3-fair-value-of-financial-instruments-1-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-3-fair-value-of-financial-instruments-financial-assets-measured-on-a-recurring-basis-1-details" name="statement-statement-note-3-fair-value-of-financial-instruments-financial-assets-measured-on-a-recurring-basis-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-3-fair-value-of-financial-instruments-financial-assets-measured-on-a-recurring-basis-details" name="statement-statement-note-3-fair-value-of-financial-instruments-financial-assets-measured-on-a-recurring-basis-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-3-fair-value-of-financial-instruments-tables" name="statement-statement-note-3-fair-value-of-financial-instruments-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-1-tables" name="statement-statement-note-4-balance-sheet-components-1-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-accrued-liabilities-1-details" name="statement-statement-note-4-balance-sheet-components-accrued-liabilities-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-accrued-liabilities-details" name="statement-statement-note-4-balance-sheet-components-accrued-liabilities-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-cash-and-cash-equivalents-and-investments-1-details" name="statement-statement-note-4-balance-sheet-components-cash-and-cash-equivalents-and-investments-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-cash-and-cash-equivalents-and-investments-details" name="statement-statement-note-4-balance-sheet-components-cash-and-cash-equivalents-and-investments-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-deferred-revenue-by-arrangement-disclosure-1-details" name="statement-statement-note-4-balance-sheet-components-deferred-revenue-by-arrangement-disclosure-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-deferred-revenue-by-arrangement-disclosure-details" name="statement-statement-note-4-balance-sheet-components-deferred-revenue-by-arrangement-disclosure-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-estimated-future-amortization-expense-1-details" name="statement-statement-note-4-balance-sheet-components-estimated-future-amortization-expense-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-estimated-future-amortization-expense-details" name="statement-statement-note-4-balance-sheet-components-estimated-future-amortization-expense-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-intangible-assets-1-details" name="statement-statement-note-4-balance-sheet-components-intangible-assets-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-intangible-assets-details" name="statement-statement-note-4-balance-sheet-components-intangible-assets-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-prepaid-expenses-and-other-current-assets-1-details" name="statement-statement-note-4-balance-sheet-components-prepaid-expenses-and-other-current-assets-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-prepaid-expenses-and-other-current-assets-details" name="statement-statement-note-4-balance-sheet-components-prepaid-expenses-and-other-current-assets-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-property-and-equipment-net-1-details" name="statement-statement-note-4-balance-sheet-components-property-and-equipment-net-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-property-and-equipment-net-details" name="statement-statement-note-4-balance-sheet-components-property-and-equipment-net-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-4-balance-sheet-components-tables" name="statement-statement-note-4-balance-sheet-components-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-6-liabilities-related-to-sale-of-future-royalties-1-tables" name="statement-statement-note-6-liabilities-related-to-sale-of-future-royalties-1-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-6-liabilities-related-to-sale-of-future-royalties-deferred-revenue-activity-1-details" name="statement-statement-note-6-liabilities-related-to-sale-of-future-royalties-deferred-revenue-activity-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-6-liabilities-related-to-sale-of-future-royalties-deferred-revenue-activity-details" name="statement-statement-note-6-liabilities-related-to-sale-of-future-royalties-deferred-revenue-activity-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-6-liabilities-related-to-sale-of-future-royalties-tables" name="statement-statement-note-6-liabilities-related-to-sale-of-future-royalties-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-7-leases-1-tables" name="statement-statement-note-7-leases-1-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-7-leases-lease-liabilities-payment-obligations-1-details" name="statement-statement-note-7-leases-lease-liabilities-payment-obligations-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-7-leases-lease-liabilities-payment-obligations-details" name="statement-statement-note-7-leases-lease-liabilities-payment-obligations-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-7-leases-operating-lease-expenses-1-details" name="statement-statement-note-7-leases-operating-lease-expenses-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-7-leases-operating-lease-expenses-details" name="statement-statement-note-7-leases-operating-lease-expenses-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-7-leases-tables" name="statement-statement-note-7-leases-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-9-stockholders-equity-1-tables" name="statement-statement-note-9-stockholders-equity-1-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-9-stockholders-equity-shares-of-common-stock-reserved-for-issuance-1-details" name="statement-statement-note-9-stockholders-equity-shares-of-common-stock-reserved-for-issuance-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-9-stockholders-equity-shares-of-common-stock-reserved-for-issuance-details" name="statement-statement-note-9-stockholders-equity-shares-of-common-stock-reserved-for-issuance-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-9-stockholders-equity-summary-of-warrants-outstanding-1-details" name="statement-statement-note-9-stockholders-equity-summary-of-warrants-outstanding-1-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-9-stockholders-equity-summary-of-warrants-outstanding-details" name="statement-statement-note-9-stockholders-equity-summary-of-warrants-outstanding-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-note-9-stockholders-equity-tables" name="statement-statement-note-9-stockholders-equity-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="vxrt_statement-statement-significant-accounting-policies-policies" name="statement-statement-significant-accounting-policies-policies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
